0001840102 true --12-31 2022 Q3 0001840102 2022-01-01 2022-09-30 0001840102 2022-11-16 0001840102 2022-09-30 0001840102 2021-12-31 0001840102 us-gaap:SeriesAPreferredStockMember 2022-09-30 0001840102 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001840102 us-gaap:SeriesBPreferredStockMember 2022-09-30 0001840102 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001840102 2022-07-01 2022-09-30 0001840102 2021-07-01 2021-09-30 0001840102 2021-01-01 2021-09-30 0001840102 spty:PreferredStockSeriesAMember 2020-12-31 0001840102 spty:PreferredStockSeriesBMember 2020-12-31 0001840102 us-gaap:CommonStockMember 2020-12-31 0001840102 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001840102 spty:SubscriptionReceivableMember 2020-12-31 0001840102 us-gaap:RetainedEarningsMember 2020-12-31 0001840102 2020-12-31 0001840102 spty:PreferredStockSeriesAMember 2021-06-30 0001840102 spty:PreferredStockSeriesBMember 2021-06-30 0001840102 us-gaap:CommonStockMember 2021-06-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001840102 spty:SubscriptionReceivableMember 2021-06-30 0001840102 us-gaap:RetainedEarningsMember 2021-06-30 0001840102 2021-06-30 0001840102 spty:PreferredStockSeriesAMember 2021-12-31 0001840102 spty:PreferredStockSeriesBMember 2021-12-31 0001840102 us-gaap:CommonStockMember 2021-12-31 0001840102 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001840102 spty:SubscriptionReceivableMember 2021-12-31 0001840102 us-gaap:RetainedEarningsMember 2021-12-31 0001840102 spty:PreferredStockSeriesAMember 2022-06-30 0001840102 spty:PreferredStockSeriesBMember 2022-06-30 0001840102 us-gaap:CommonStockMember 2022-06-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001840102 spty:SubscriptionReceivableMember 2022-06-30 0001840102 us-gaap:RetainedEarningsMember 2022-06-30 0001840102 2022-06-30 0001840102 spty:PreferredStockSeriesAMember 2021-01-01 2021-09-30 0001840102 spty:PreferredStockSeriesBMember 2021-01-01 2021-09-30 0001840102 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001840102 spty:SubscriptionReceivableMember 2021-01-01 2021-09-30 0001840102 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001840102 spty:PreferredStockSeriesAMember 2021-07-01 2021-09-30 0001840102 spty:PreferredStockSeriesBMember 2021-07-01 2021-09-30 0001840102 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001840102 spty:SubscriptionReceivableMember 2021-07-01 2021-09-30 0001840102 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001840102 spty:PreferredStockSeriesAMember 2022-01-01 2022-09-30 0001840102 spty:PreferredStockSeriesBMember 2022-01-01 2022-09-30 0001840102 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001840102 spty:SubscriptionReceivableMember 2022-01-01 2022-09-30 0001840102 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001840102 spty:PreferredStockSeriesAMember 2022-07-01 2022-09-30 0001840102 spty:PreferredStockSeriesBMember 2022-07-01 2022-09-30 0001840102 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001840102 spty:SubscriptionReceivableMember 2022-07-01 2022-09-30 0001840102 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001840102 spty:PreferredStockSeriesAMember 2021-09-30 0001840102 spty:PreferredStockSeriesBMember 2021-09-30 0001840102 us-gaap:CommonStockMember 2021-09-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001840102 spty:SubscriptionReceivableMember 2021-09-30 0001840102 us-gaap:RetainedEarningsMember 2021-09-30 0001840102 2021-09-30 0001840102 spty:PreferredStockSeriesAMember 2022-09-30 0001840102 spty:PreferredStockSeriesBMember 2022-09-30 0001840102 us-gaap:CommonStockMember 2022-09-30 0001840102 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001840102 spty:SubscriptionReceivableMember 2022-09-30 0001840102 us-gaap:RetainedEarningsMember 2022-09-30 0001840102 srt:ScenarioPreviouslyReportedMember 2022-09-30 0001840102 srt:RestatementAdjustmentMember 2022-09-30 0001840102 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesBPreferredStockMember 2022-09-30 0001840102 srt:RestatementAdjustmentMember us-gaap:SeriesBPreferredStockMember 2022-09-30 0001840102 srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001840102 srt:RestatementAdjustmentMember 2022-07-01 2022-09-30 0001840102 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-09-30 0001840102 srt:RestatementAdjustmentMember 2022-01-01 2022-09-30 0001840102 2020-11-25 2020-12-31 0001840102 2020-12-01 2020-12-31 0001840102 spty:PickpocketIncMember 2021-01-13 0001840102 spty:PickpocketIncMember 2021-01-12 2021-01-13 0001840102 2022-01-02 0001840102 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-09-30 0001840102 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-09-30 0001840102 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-09-30 0001840102 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-11-25 2020-11-26 0001840102 us-gaap:CommonStockMember 2020-11-25 2020-11-26 0001840102 us-gaap:InvestorMember 2021-01-01 2021-09-30 0001840102 us-gaap:PreferredStockMember 2022-09-30 0001840102 us-gaap:InvestorMember 2022-01-01 2022-09-30 0001840102 spty:ConsultantsMember 2022-01-01 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q/A#1

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 333-257323

 

SPECIFICITY, INC.

 

(Exact name of registrant as specified in its charter)

 

Nevada   85-4017786
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
410 S. Ware Blvd., Suite 508, Tampa, FL   33619
(Address of principal executive offices)   (Zip Code)

 

(813) 364-4744

 

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer Accelerated filer
Non-accelerated Filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 9,867,183 shares of common stock as of November 16, 2022.

 

 

 

 

 

 

 

 

EXPLANATORY NOTE ON AMENDMENT

 

This Amendment No. 1 to Form 10-Q (“Amendment”) amends the Quarterly Report for the three and nine months ended September 30, 2022 originally filed on November 21, 2022.

 

On December 7, 2022, management of Specificity, Inc. (the “Company”) identified that previously filed financial statements as of September 30, 2022 and for the three and nine months then ended required restatement. The restatement was the result of the Company entering into various consulting agreements which contained equity components which were not initially accounted for. In addition, due to a formula error the original statement of operations for the three months ended September 30, 2022 reflected the six months ended September 30, 2022 rather than the three months ended September 30, 2022.

 

 

 

SPECIFICITY, INC.

 

TABLE OF CONTENTS

 

    Page
PART I - FINANCIAL INFORMATION
       
Item 1. Financial Statements   F-1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   1
Item 3. Quantitative and Qualitative Disclosures About Market Risk   4
Item 4. Controls and Procedures   4
       
PART II - OTHER INFORMATION
       
Item 1. Legal Proceedings   6
Item 1A. Risk Factors   6
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   6
Item 3. Defaults Upon Senior Securities   6
Item 4. Mine Safety Disclosures   6
Item 5. Other Information   6
Item 6. Exhibits   7
       
Signatures   8

 

-i-

Table of Contents

SPECIFICTY, INC.
FINANCIAL STATEMENTS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021
INDEX TO FINANCIAL STATEMENTS
(UNAUDITED)

 

    Pages
Balance Sheets   F-2
     
Statements of Operations   F-3
     
Statement of Stockholders’ Equity (Deficit)   F-4
     
Statement of Cash Flows   F-5
     
Notes to the Financial Statements   F-6

 

 

F-1

Table of Contents

SPECIFICITY, INC
BALANCE SHEETS
(UNAUDITED)

 

           
   As of
September 30,
2022
   As of
December 31,
2021
 
Assets:  (as restated)    
Current assets          
Cash and cash equivalents  $172,594   $637,841 
Accounts receivable   10,000    - 
Prepaid expenses and other current assets   402,001    6,851 
Total current assets   584,595    644,692 
           
Property and equipment, net   73,362    70,423 
Right of use asset    74,911    - 
           
Total assets  $732,868   $715,115 
           
Liabilities and Stockholders' Deficit:          
Current liabilities:          
Account payable  $68,350   $24,511 
Accrued liabilities   23,681    70,423 
Advances, related party   33,000    - 
Right of use liability   43,260    - 
Total current liabilities   168,291    94,934 
           
Long term liabilities -          
Related party notes payable   990,000    1,000,000 
Right of use liability, net of current portion   31,651    - 
           
Total liabilities   1,189,942    1,094,934 
           
           
Commitments and contingencies          
           
Stockholders' Deficit:          
Preferred stock, Series A; $0.001 par value; 1,000,000 shares authorized; 1,000,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021   1,000    1,000 
Preferred stock, Series B; $0.001 par value; 560,000 and 260,000 shares authorized; 560,000 and 260,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021   1,400,000    650,000 
Common stock, $0.001 par value; 50,000,000 shares authorized, 10,430,441 and 8,654,701 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively   10,430    8,655 
Additional paid-in capital   4,097,034    14,18,896 
Subscriptions receivable   (1,500)   (1,500)
Accumulated deficit   (5,964,038)   (2,456,870)
Total stockholders' deficit   (457,074)   (379,819)
Total liabilities and stockholders' deficit  $732,868   $715,115 

 

See accompanying notes to the financial statements.

 

F-2

Table of Contents

SPECIFICITY, INC

STATEMENTS OF OPERATIONS

(UNAUDITED)

 

                     
   For the
Three Months Ended
September 30,
2022
   For the
Three Months Ended
September 30,
2021
   For the
Nine Months Ended
September 30,
2022
   For the
Nine Months Ended
September 30,
2021
 
   (as restated)    (as restated)
Revenue, net  $284,311   $214,106   $933,821   $540,412 
Cost of revenues   228,510    87,614    489,760    240,418 
Gross profit   55,801    126,492    444,061    299,994 
                     
Operating expenses:                    
Sales and marketing   56,368    3,845    89,085    23,732 
General and administrative expenses   1,742,707    260,112    3,665,447    704,748 
Officer compensation   44,699    20,272    161,217    1,163,235 
Total operating expenses   1,843,774    284,229    3,915,749    1,891,715 
                     
Loss from operations   (1,787,973)   (157,737)   (3,471,688)   (1,591,721)
                     
Other income (expense):                    
Interest expense - related party   (12,466)   (35,417)   (35,480)   (35,417)
Total other income (expense)   (12,466)   (35,417)   (35,480)   (35,417)
                     
Net loss  $(1,800,439)  $(193,154)  $(3,507,168)  $(1,627,138)
                     
Basic and diluted net loss per common share attributable to common stockholders  $(0.18)  $(0.02)  $(0.37)  $(0.21)
Weighted-average number of shares used in computing basic and diluted per share amounts   10,041,000    7,836,232    9,470,004    7,803,822 

 

 

See accompanying notes to the financial statements.

 

F-3

Table of Contents

SPECIFICITY, INC

STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

(UNAUDITED)

 

                                                   
   Preferred Stock,
Series A
   Preferred Stock,
Series B
   Common Stock   Additional
Paid-in
   Subscription   Accumulated   Total
Stockholders'
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Receivable   Deficit   Equity (Deficit) 
Balance, December 31, 2020   1,000,000   $1,000    260,000   $650,000    7,670,000   $7,670   $76,330   $(422,500)  $(75,465)  $237,035 
                                                   
Issuance of common stock for cash   -    -    -    -    281,667    282    357,218    22,500    -    380,000 
Issuance of preferred stock for cash   -    -    -    -    -    -    -    200,000    -    200,000 
Net loss   -    -    -    -    -    -    -    -    (1,627,138)   (1,627,138)
Balance, September 30, 2021   1,000,000   $1,000    260,000   $650,000    7,951,667   $7,952   $433,548   $(200,000)  $(1,702,603)  $(810,103)

 

   Preferred Stock,
Series A
   Preferred Stock,
Series B
   Common Stock   Additional
Paid-in
   Subscription   Accumulated   Total
Stockholders'
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Receivable   Deficit   Deficit 
Balance, June 30, 2021   1,000,000   $1,000    260,000   $650,000    7,825,000   $7,825   $253,675   $(200,000)  $(1,509,449)  $(796,949)
                                                   
Issuance of common stock for cash   -    -    -    -    126,667    127    179,873    -    -    180,000 
Issuance of preferred stock for cash   -    -    -    -    -    -    -    -    -    - 
Net loss   -    -    -    -    -    -    -    -    (193,154)   (193,154)
Balance, September 30, 2021   1,000,000   $1,000    260,000   $650,000    7,951,667   $7,952   $433,548   $(200,000)  $(1,702,603)  $(810,103)

 

   Preferred Stock,
Series A
   Preferred Stock,
Series B
   Common Stock   Additional
Paid-in
   Subscription   Accumulated   Total
Stockholders'
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Receivable   Deficit   Deficit 
Balance, December 31, 2021   1,000,000   $1,000    260,000   $650,000    8,654,701   $8,655   $1,418,896   $(1,500)  $(2,456,870)  $(379,819)
                                                   
Issuance of common stock for cash   -    -    -    -    812,482    812    1,262,901    -    -    1,263,713 
Offering costs   -    -    -    -    -    -    (28,685)   -    -    (28,685)
Stock-based compensation   -    -    300,000    750,000    963,258    963    1,443,922    -    -    2,194,885 
Net loss   -    -    -    -    -    -    -    -    (3,507,168)   (3,507,168)
Balance, September 30, 2022 (as restated)   1,000,000   $1,000    560,000   $1,400,000    10,430,441   $10,430   $4,097,034   $(1,500)  $(5,964,038)  $(457,074)

 

    Preferred Stock, Series A    Preferred Stock, Series B   Common Stock   Additional
Paid-in
   Subscription   Accumulated   Total
Stockholders'
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Receivable   Deficit   Deficit 
Balance, June 30, 2022   1,000,000   $1,000    260,000   $650,000    9,369,345   $9,369   $2,467,318   $(1,500)  $(4,163,599)  $(1,037,412)
                                                   
Issuance of common stock for cash   -    -    -    -    497,838    498    791,248    -    -    791,746 
Offering costs   -    -    -    -    -    -    (5,854)   -    -    (5,854)
Stock-based compensation   -    -    300,000    750,000    563,258    563    844,322    -    -    1,594,885 
Net loss   -    -    -    -    -    -    -    -    (1,800,439)   (1,800,439)
Balance, September 30, 2022 (as restated)   1,000,000   $1,000    560,000   $1,400,000    10,430,441   $10,430   $4,097,034   $(1,500)  $(5,964,038)  $(457,074)

 

See accompanying notes to the financial statements.

 

F-4

Table of Contents

SPECIFICITY, INC

STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

           
   For the
Nine Months Ended September 30,
2022 
   For the
Nine Months Ended September 30,
2021 
 
   (as restated)       
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(3,507,168)  $(1,627,138)
Adjustments to reconcile net loss to net cash
  used in operating activities:
          
Stock-based compensation   1,637,831    - 
Depreciation   7,342    - 
Acquistion of Pick Pocket and subscription payable treated as officer compensation   -    1,000,000 
Changes in operating assets and liabilities:          
Accounts receivable   (10,000)   7,250 
Prepaids and other current assets   161,904    - 
Accounts payable   43,839    (10,746)
Accrued liabilities   (46,742)   - 
Accrued interest, related party   -    35,417 
Net cash used in operating activities   (1,712,994)   (595,217)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (10,281)   - 
Net cash used in investing activities   (10,281)   - 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from subscription receivables   -    222,500 
Payments on notes payable   (10,000)   (30,000)
Advances from related party   33,000    - 
Payment of deferred offering costs   (28,685)   (54,801)
Proceeds from sale of common stock   1,263,713    357,500 
Net cash provided by financing activities   1,258,028    495,199 
           
Change in cash and cash equivalents   (465,247)   (100,018)
Cash and cash equivalents, beginning of period   637,841    217,108 
Cash and cash equivalents, end of period  $172,594   $117,090 
           
Supplemental disclosures of cash flow information:          
Cash paid for interest  $60,548   $- 
Cash paid for income taxes  $-   $- 
           
Non-cash investing and financing activities:          
Issuance of a related party notes payable for Pick Pocket  $-   $1,000,000 
Right of use asset and liability  $104,665   $- 
Prepaid through issuance of common stock  $557,054   $- 

 

See accompanying notes to the financial statements.

 

F-5

Table of Contents

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Specificity, Inc. (the “Company”) is a Nevada Corporation incorporated on November 25, 2020 (“Inception”).

 

The Company is a full-service digital marketing firm that delivers cutting-edge marketing solutions to business-to-business clients as well as business to consumer clients. The Company has developed tools that allow us to identify and market to people who are actively in the buying cycle. We take advantage of the real-time messaging opportunities digital marketing offers to give small and medium-sized businesses a fair chance at online traffic.

 

Restatement

 

On December 7, 2022, management of Specificity, Inc. (the “Company”) identified that previously filed financial statements as of September 30, 2022 and for the three and nine months then ended required restatement. The restatement was the result of the Company entering into various consulting agreements which contained equity components which were not initially accounted for. In addition, due to a formula error the original statement of operations for the three months ended September 30, 2022 reflected the six months ended September 30, 2022 rather than the three months ended September 30, 2022.

 

See Note 7 for disclosure of the equity related items and the financial statement impact.

 

The following is the impact of the restatement on the balance sheet as of September 30, 2022:

 

               
   As of
September 30,
2022
   As of
September 30,
2022
   Difference 
Assets:   (as filed)   (as restated)      
Current assets               
Prepaid expenses and other current assets   30,632    402,001   $371,369 
Total current assets   213,226    584,595    371,369 
                
Total assets  $361,499   $732,868   $371,369 
Stockholders defecit               
Preferred stock, Series B; $0.001 par value; 560,000 and 260,000 shares authorized; 560,000 and 260,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021   650,000    1,400,000   $750,000 
Common stock, $0.001 par value; 50,000,000 shares authorized, 10,430,441 and 8,654,701 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively   9,867    10,430    563 
Additional paid-in capital   3,252,712    4,097,034    844,322 
Accumulated deficit   (4,740,522)   (5,964,038)   (1,223,516)
Total stockholders' deficit   (828,443)   (457,074)   371,369 
Total liabilities and stockholders' deficit  $361,499   $732,868   $371,369 

 

F-6

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

The following is the impact of the restatement on the statements of operations for the three months ended September 30, 2022:

 

                
   For the
Three Months Ended
September 30,
2022
   For the
Three Months Ended
September 30,
2022
   Change 
   (as reported)   (as restated)      
Revenue, net  $662,971   $284,311   $(378,660)
Cost of revenues   338,870    228,510    (110,360)
Gross profit   324,101    55,801    (268,300)
                
Operating expenses:               
Sales and marketing   76,205    56,368    (19,837)
General and administrative expenses   1,106,802    1,742,707    635,905 
Officer compensation   65,687    44,699    (20,988)
Total operating expenses   1,248,694    1,843,774    595,080 
                
Loss from operations   (924,593)   (1,787,973)   (863,380)
                
Other income (expense):               
Interest expense - related party   (24,932)   (12,466)   12,466 
Total other income (expense)   (24,932)   (12,466)   12,466 
                
Income (loss) before provision for income taxes   (949,525)   (1,800,439)   (850,914)
                
Net loss  $(949,525)  $(1,800,439)  $(850,914)
                
Net income attributable to common stockholders  $(949,525)  $(1,800,439)  $(850,914)
                
Diluted net income (loss) per common share attributable to common stockholders  $(0.10)  $(0.18)  $(0.08)
Weighted-average number of shares used in computing dilutive per share amounts   9,660,352    10,041,000    380,648 

 

The following is the impact of the restatement on the statements of operations for the nine months ended September 30, 2022:

 

                
   For the
Nine Months Ended
September 30,
2022
   For the
Nine Months Ended
September 30,
2022
   Change 
   (as reported)   (as restated)     
Operating expenses:               
General and administrative expenses  $2,441,931   $3,665,447   $1,223,516 
Total operating expenses   2,692,233    3,915,749    1,223,516 
                
Loss from operations   (2,248,172)   (3,471,688)   (1,223,516)
                
Income (loss) before provision for income taxes   (2,283,652)   (3,507,168)   (1,223,516)
                
Net loss  $(2,283,652)  $(3,507,168)  $(1,223,516)
                
Net income attributable to common stockholders  $(2,283,652)  $(3,507,168)  $(1,223,516)
                
Diluted net income (loss) per common share attributable to common stockholders  $(0.25)  $(0.37)  $(0.12)
Weighted-average number of shares used in computing dilutive per share amounts   9,303,672    9,470,004    166,332 

 

F-7

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

The following is the impact of the restatement on the consolidated statement of cash flows for the nine months ended September 30, 2022:

 

                
   Nine Months Ended
September 30, 2022
   Change 
   (as reported)   (as restated)      
CASH FLOWS FROM OPERATING ACTIVITIES:               
Net loss  $(2,283,652)  $(3,507,168)  $(1,223,516)
Adjustments to reconcile net loss to net cash
used in operating activities:
               
Stock-based compensation   600,000    1,637,831    1,037,831 
Changes in operating assets and liabilities:               
Related party receivables   (23,781)   161,904    185,685 
Net cash used in operating activities  $(1,712,994)  $(1,712,994)  $- 
                
Non-cash investing and financing activities:               
Prepaid through issuance of common stock  $-   $557,054   $557,054 

 

The impact to the statement of stockholders’ deficit is detailed above within net loss on the statement of operations and stock-based compensation on the statement of cashflows for the three and nine months.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited interim consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these consolidated financial statements have been included. Such adjustments consist of normal recurring adjustments. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2021. The results of operations for the nine months ended September 30, 2022 are not indicative of the results that may be expected for the full year.

 

Use of Estimates

 

The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentration of Credit Risk

 

Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.

 

Lease Commitment

 

The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable. Operating lease right of use (“ROU”) assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases buildings (real estate) which are classified as operating leases. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company’s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.

 

F-8

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met.

 

Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.

 

Variable lease payments not dependent on a rate or index associated with the Company’s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments are presented as operating expenses in the Company’s statement of operations in the same line as expense arising from fixed lease payments. As of September 30, 2022, management determined that there were no variable lease costs.

 

Fair Value Measurements

 

The Company follows FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) to measure and disclosure the fair value of its financial instruments. ASC 820 establishes a framework for measuring fair value in U.S. GAAP and expands disclosures about fair value measurements and establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The three levels of fair value hierarchy defined by ASC 820 are described below:

 

Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
   
Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
   
Level 3 Pricing inputs that are generally unobservable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

The carrying amounts reported in the Company’s financial statements for cash, accounts receivable, prepaids and other current assets, accounts payable, etc. approximate their fair value because of the immediate or short-term mature of these financial instruments.

 

Per Share Information

 

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period, increased by the potentially dilutive common shares that were outstanding during the period. As of September 30, 2022 and 2021, the Company does not have any dilutive shares.

 

F-9

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

New Accounting Pronouncements

 

In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements, which provided an alternative transition method when initially applying ASU 2016-02. Companies may elect to apply ASU 2016-02 at the beginning of the earliest period presented or recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. The ASU is effective for annual and interim periods beginning after December 15, 2021. Management adopted this standard on January 1, 2022, which a right of use asset and liability were recorded in connection with the Company’s lease.

 

The FASB issues ASUs to amend the authoritative literature in ASC. There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.

 

NOTE 3 – GOING CONCERN (as restated)

 

As reflected in the accompanying financial statements, during the nine months ended September 30, 2022, the Company incurred a net loss of $3,507,168 and used cash of $1,712,994 in operating activities. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. We have evaluated the conditions or events that raise substantial doubt about the Company’s ability as a going concern within one year of issuance of the financial statements.

 

While the Company is continuing operations and generating revenues, the Company’s cash position is not significant enough to support the Company’s daily operations. To fund operations and reduce the working capital deficit, the Company has raised capital through the sale of common and preferred stock. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect, nor can there be assurance that such funds will be at acceptable terms. See Note 7 for additional funds received during the nine months ended September 30, 2022. The ability of the Company to continue as a going concern is dependent upon our ability to further implement its business plan and generate revenues and cash flows. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

NOTE 4 – FINANCIAL STATEMENT ELEMENTS

 

During the period from Inception to December 31, 2020, the Company purchased software for which is to be used in operations with a $50,000 note payable. The software isn’t expected to be implemented until late-2022 and thus no amortization was recorded at September 30, 2022. See Note 5 for discussion of the note payable terms.

 

NOTE 5 – NOTES PAYABLE

 

The Company entered into a $50,000 note payable in connection with the purchase of software, see Note 4. The note payable does not incur interest and required five monthly payments of $10,000 which were paid during 2021.

 

On January 13, 2021, the Company entered into a share purchase agreement with the Company’s Chief Executive Officer to acquire 80% of Pickpocket, Inc. (“Pickpocket”) for a purchase price of $1.0 million in the form of a promissory note. As of the date of acquisition, Pickpocket did not have any operations or significant assets. Upon acquisition, the Company expensed the $1.0 million as compensation to officer. The transaction was accounted for on a carry-over basis as the Chief Executive Officer was the controlling shareholder in both entities. The promissory note incurs interest at a rate of 5% per annum. During the nine months ended September 30, 2022, the Company paid interest of $60,548. As of September 30, 2022, the Company has prepaid interest of $25,068 included within prepaids on the accompanying balance sheet.

 

NOTE 6 – COMMITMENTS AND CONTIGENCIES

 

Lease

 

The Company leases offices used for operations under a non-cancelable agreement. Rent expense for the three and nine months ended September 30, 2022 was $17,896 and $95,536, respectively. On January 1, 2022, the Company recorded a right of use asset and liability of $104,665. The Company used an effective borrowing rate of 3% which is the annual increase per the lease agreement.

 

F-10

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

Litigation

 

The Company is not party to any pending or threatened litigation.

 

Significant Contracts

 

On January 1, 2021, the Company entered into an employment contract with its Chief Executive Officer for which the initial term of the agreement is for one year and renews automatically annually. If the Chief Executive Officer is terminated without cause, then the remaining current contract year shall be paid. During the nine months ended September 30, 2022 and 2021, the Company paid either the Chief Executive Officer and/or entities affiliated with the Chief Executive Officer $161,217 and $1,163,235, respectively, which has been classified as officer compensation on the accompanying statements of operations.

 

See Notes 5 and 7 for additional payments to the related party.

 

NOTE 7 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Series A Preferred Stock

 

The Company is authorized to issue 1,000,000 shares of $0.001 par value Series A preferred stock (“Series A”). The holder of the Series A preferred stock is entitled to 80% of all voting rights available at the time of any vote. In the event of liquidation or dissolution of the Company, holders of Series A preferred stock are entitled to share ratably in all assets remaining after payment of liabilities and have no liquidation preferences. Holders of Series A preferred stock have a right to convert each share of Series A into five shares common stock. See below for discussion regarding issuance of Series A preferred stock.

 

Series B Preferred Stock (as restated)

 

During September 2022, the Company increased the Series B preferred stock authorized shares to 560,000 from 260,000. The Company is authorized to issue 560,000 shares of $0.001 par value Series B preferred stock (“Series B”). The holder of the Series B preferred stock do not have voting rights. In the event of liquidation or dissolution of the Company, holders of Series B preferred stock are entitled to share ratably in all assets remaining after payment of liabilities and have no liquidation preferences. Holders of Series B preferred stock have a right to convert in the pro rata portion of exactly ten percent of the issued and outstanding common stock of the Company.

 

Common Stock (as restated)

 

The Company is authorized to issue 50,000,000 shares of $0.001 par value common stock. The holders of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders.

 

At Inception, the Company issued 1,000,000 shares of Series A preferred stock and 7,500,000 shares of common stock to founders of the Company for no consideration.

 

During the nine months ended September 30, 2021 the Company sold 281,667 shares of common stock to various investors at prices ranging from $0.50 to $1.50 per share resulting in gross proceeds of $357,500. During the nine months ended September 30, 2021 there were $22,500 and $200,000 in subscriptions receivable sold of common and preferred stock, respectively.

 

During the nine months ended September 30, 2022 the Company sold 812,482 shares of common stock to various investors at $1.50 per share resulting in gross proceeds of $1,263,713. Offering costs related to the sale of these shares amounted to $28,685 As of September 30, 2022, there were no subscriptions receivable related to these sales.

 

During the nine months ended September 30, 2022, the Company issued 426,256 shares of common stock to consultants for management guidance, market research, investor reports, capital raising services, etc. During the three and nine months ended September 30, 2022, the Company recorded $77,831 in stock-based compensation. The Company valued the shares based upon the recent sales of common stock. In connection with one of these issuances, the Company recorded a prepaid of $557,054 and is amortizing over the term of the agreement of one year. As of September 30, 2022, the prepaid was $371,369. In addition, this same agreement contains provisions for which additional shares would be issued. These provisions include 10% commission on all gross sales introduced by the consultant, 3% of an equity interest in the Company for introduction which results in a $5.0 million investment and an additional 3% equity interest for introduction which results in $15.0 million investment.

 

During the nine months ended September 30, 2022, the Company issued 540,000 shares of common stock and 300,000 shares of Series B preferred stock to two employees for services rendered. One of the individuals is a significant shareholder and the sole shareholder of the Series B preferred stock. The Company recorded $960,000 and $1,560,000 as stock-based compensation, within general and administrative expense, in connection with the issuances, during the three and nine months ended September 30, 2022, respectively. The Company valued the shares based upon the recent sales of common stock.

 

F-11

SPECIFICITY, INC.
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)

 

NOTE 8 – SUBSEQUENT EVENTS

 

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that no material subsequent events exist other than those disclosed.

 

F-12

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Cautionary Note Regarding Forward-Looking Information and Factors That May Affect Future Results

 

This quarterly report on Form 10-Q contains forward-looking statements regarding our business, financial condition, results of operations and prospects. The Securities and Exchange Commission (the “SEC”) encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This quarterly report on Form 10-Q and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management’s plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated sales efforts, expenses, the outcome of contingencies, such as legal proceedings, and financial results. Factors that could cause our actual results of operations and financial condition to differ materially are set forth in the “Risk Factors” section of our Form S-1 filed with the Commission on September 13, 2022.

 

We caution that these factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q.

 

Business Overview

 

The discussion and analysis of our financial condition and results of operations are based on our financial statements, which we have prepared in accordance with accounting principles generally accepted in the United States of America. This discussion should be read in conjunction with the other sections of this Form 10-Q, including “Risk Factors” as described in our Form S-1 as filed with the Commission on September 13, 2022, and the Financial Statements. The various sections of this discussion contain a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risk factors described throughout our Annual Report on Form 10-K and our Form S-1 as filed with the Commission on September 13, 2022. See “Forward-Looking Statements.” Our actual results may differ materially. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

As used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” except where the context otherwise requires, the term “we,” “us,” “our,” or “the Company,” refers to the business of Specificity, Inc.

 

Organizational Overview

 

Specificity, Inc. (“Specificity” or the “Company”) was incorporated in the State of Nevada on November 25, 2020.

 

-1-

Table of Contents

The Problem We Endeavor to Solve

 

Big Tech and the Social Media giants have all evolved away from client advocacy and moved into a new paradigm of fear and hyper political correctness. They no longer endeavor to do what is right for their marketing clients. Instead, they have made marketing to targeted audiences exponentially more difficult and dramatically more expensive.

 

After the fallout from the social media giants getting caught misusing user supplied data (for example Cambridge Analytica) they pulled most of the targeting mechanisms out of their platforms to avoid additional congressional oversight and regulation. They have since gone a step further by claiming the rationale for these changes is to stop discrimination.

 

We believe the real motivation for this policy change is not anti-discrimination, rather it is revenue driven. They are forcing ad delivery to consumers unlikely to buy. They are also forcing increased quantities of ads to be placed in order to hit an impactful number of targeted buyers. As a result, businesses are deploying the same budget with diminished results or are forced to increase their spend to keep the net results the same. Their claim is that using peoples’ interests and behavior to identify suitable audiences to market to is suddenly discriminatory. These companies have used these practices for well over a decade. Targeting buyers with incomes that suggest they can afford a six-figure sports car isn’t discrimination; it’s the responsible deployment of advertising spend. Conversely, delivery of ads for low-income housing opportunities to wealthy people makes just as little sense as well.

 

At best its political correctness run amuck at worst it’s a ploy to drive ad spend up by forcing people to spend more to get the same. And not only will we take no part in this, we are building Specificity specifically to help businesses get the very most for their ad spend. Our marketing tools will target those most likely to buy the product being solicited. We would never allow nor condone discrimination of any kind. But delivering advertising to people actively looking for products and services is NOT discrimination; it’s intelligent marketing. 

 

Company Overview

 

Specificity, Inc. is a technology company with 2 core missions:

 

  1) First, we endeavor to deliver the latest digital marketing technology to companies of all sizes making them nationally, regionally, and locally competitive. In this capacity, we come to the table already vertically integrated and capable of executing any size campaign flawlessly.

 

  2) Secondarily, Specificity is a tech incubator. We identify technology-based marketing solutions, take an equity share position in return for utilizing our internal resources to complete the buildout of technology-based solutions, and then using our marketing prowess to draw clients to these businesses. We have the internal personnel to successfully complete these projects and our marketing capabilities will deliver lower advertising costs to launch new projects making growth faster to attain.

 

We are currently a development stage company with minimal revenues, though we had a significant increase in revenues for the year ended December 31, 2021. Accordingly, management has concluded that there is substantial doubt in our ability to continue as a going concern (please refer to the footnotes to the financial statements). As of September 30, 2022, the Company is still unable to establish a consistent flow of revenues from our operations which is sufficient to sustain our operating needs, management intends to rely primarily upon debt financing to supplement cash flows, if any, generated by our services. We will seek out such financing as necessary to allow the Company to continue to grow our business operations, and to cover such cost, excluding professional fees, associated with being a reporting Company with the Securities and Exchange Commission (“SEC”). The Company has included such costs to become a publicly reporting company in its targeted expenses for working capital expenses and intends to seek out reasonable loans from friends, family, and business acquaintances if it becomes necessary. At this point we have been funded by our founders and initial shareholders and have not received any firm commitments or indications from any family, friends, or business acquaintances regarding any potential investment in the Company except those shareholders listed herein.

 

-2-

Table of Contents

Results of Operations – Three Months Ended September 30, 2022, vs 2021 (as restated)

 

Revenues

 

For the quarter ended September 30, 2022, and the quarter ended September 30, 2021, we generated $284,311 and $214,106 in revenues, respectively. The increase in revenues was due to the continued focus on the expansion of our operations.

 

Operating Expenses

 

For the quarter ended September 30, 2022, and the quarter ended September 30, 2021, we incurred $1,843,774 and $284,229 in operating expenses, respectively. The increase in Operating Expenses was due primarily to an increase in general and administrative expenses, an increase in sales and marketing expenses, and an increase in officer compensation due to the continued expansion of our operations. In addition, during the quarter ended September 30, 2022 we recorded a significant amount of stock-based compensation.

 

Results of Operations – Nine Months Ended September 30, 2022, vs 2021 (as restated)

 

Revenues

 

For the nine months ended September 30, 2022, and the nine months ended September 30, 2021, we generated $933,821 and $540,412 in revenues, respectively. The increase in revenues was due to the continued focus on the expansion of our operations.

 

Operating Expenses

 

For the nine months ended September 30, 2022, and the nine months ended September 30, 2021, we incurred $3,915,749 and $1,891,715 in operating expenses, respectively. The increase in operating expenses was due primarily to an increase in our operations which resulted in an increase in general and administrative expenses, an increase in sales and marketing expenses, with a decrease in officer compensation due to recording a significant amount of compensation related to PickPocket in the prior comparable period. In addition, during the nine months ended September 30, 2022 we recorded a significant amount of stock-based compensation.

 

Liquidity, Capital Resources, and Off-Balance Sheet Arrangements

 

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had available cash on hand of $172,594 as of September 30, 2022, as compared to $637,841 as of December 31, 2021. The decrease in capital was directly related to funding our operations in 2022.

 

Cash flows for the nine months ended September 30, 2022.

 

Net cash flow derived from operating activities was $(1,712,994) for the nine months ended September 30, 2022. This is due primarily to a net loss of $3,507,168, offset by $1,637,831 in the stock-based compensation and $43,839 in accounts payable. The increase is primarily due to the expansion of our operations.

 

Net cash flow used in investing activities was $(10,281) for the nine months ended September 30, 2022, and $0 for the nine months ended September 30, 2021.

 

Net cash provided by financing activities was $1,258,028 for the nine months ended September 30, 2022 and consisted of $1,263,713 from the proceeds from the sale of common stock, $33,000 from advances, $(10,000) from payments on notes payable, and $(28,685) from the payment of deferred offering costs. The Company continues to raise capital to fund operations.

 

-3-

Table of Contents

Cash Requirements

 

Our management does not believe that our current capital resources will be adequate to continue operating our company and maintaining our business strategy for much more than 12 months. At the date hereof, we have minimal cash at hand. We require additional capital to implement our business and fund our operations.

 

Since inception we have funded our operations primarily through equity financings and we expect that we will continue to fund our operations through the equity and debt financing, either alone or through strategic alliances. Additional funding may not be available on favorable terms, if at all. We intend to continue to fund our business by way of equity or debt financing until natural revenues can support the Company. If we raise additional capital through the issuance of equity or convertible debt securities, the percentage ownership of our company held by existing shareholders will be reduced and those shareholders may experience significant dilution. In addition, new securities may contain certain rights, preferences or privileges that are senior to those of our common stock. We cannot assure you that we will be able to raise the working capital as needed in the future on terms acceptable to us, if at all.

 

If we are unable to raise capital as needed, we are required to reduce the scope of our business development activities, which could harm our business plans, financial condition, and operating results, or cease our operations entirely, in which case, you will lose all of your investment.

 

Off-Balance Sheet Arrangements

 

Not applicable.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure controls and procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports, filed under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, a control may become inadequate because of changes in conditions or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

As required by the SEC Rules 13a-15(b) and 15d-15(b), we carried out an evaluation under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due to material weaknesses in internal controls over financial reporting. 

 

-4-

Table of Contents

To address these material weaknesses, management engaged financial consultants, performed additional analyses and other procedures to ensure that the financial statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

 

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Audit Standard No. 5, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that as of September 30, 2022, our internal controls over financial reporting were not effective at the reasonable assurance level:

 

1. We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us for the months ended September 30, 2022. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

2. We do not have sufficient resources in our accounting function, which restricts the Company’s ability to gather, analyze and properly review information related to financial reporting in a timely manner. In addition, due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

3. We do not have personnel with sufficient experience with United States generally accepted accounting principles to address complex transactions.

 

4. We have inadequate controls to ensure that information necessary to properly record transactions is adequately communicated on a timely basis from non-financial personnel to those responsible for financial reporting. Management evaluated the impact of the lack of timely communication between non–financial personnel and financial personnel on our assessment of our reporting controls and procedures and has concluded that the control deficiency represented a material weakness.

 

5. We have determined that oversight over our external financial reporting and internal control over our financial reporting is ineffective. The Chief Financial Officer has not provided adequate review of the Company’s SEC’s filings and financial statements and has not provided adequate supervision and review of the Company’s accounting personnel or oversight of the independent registered accounting firm’s audit of the Company’s financial statement.

 

We have taken steps to remediate some of the weaknesses described above, including by engaging a financial reporting advisor with expertise in accounting for complex transactions. We intend to continue to address these weaknesses as resources permit.

 

Changes in internal control over financial reporting

 

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

-5-

Table of Contents

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We know of no material, existing, or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to provide the information required by this item. However, please refer to our Form 10-K as filed with the Commission on April 15, 2022, and our Form S-1 as filed with the Commission on September 13, 2022, to see those Risk Factors listed therein.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Except for founders shares all unregistered shares have since been registered pursuant to the Form S-1 registration statement deemed effective on September 16, 2021, the Form S-1 registration statement deemed effective on June 1, 2022, and the Form S-1 Registration statement deemed effective on September 23, 2022.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

-6-

Table of Contents

ITEM 6. EXHIBITS

 

Exhibit No.   Description of Exhibit
31.1*   Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002.
     
32.1*   Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002.
     
101.INS*   XBRL INSTANCE DOCUMENT
     
101.SCH*   XBRL TAXONOMY EXTENSION SCHEMA
     
101.CAL*   XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
     
101.DEF*   XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
     
101.LAB*   XBRL TAXONOMY EXTENSION LABEL LINKBASE
     
101.PRE*   XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

 

 
*Filed herewith.

 

-7-

Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  SPECIFICITY, INC.
     
Dated: December 29, 2022 By: /s/ Jason Wood
    Jason Wood

 

-8-